It appears that in esophageal cells the expression of LINE-1 and Alu RNA sequences precede the Tp53 mutations, while in triple negative breast cancers the Tp53 mutations precede the expression of Alu and LINE-1 RNA sequences. This evidence concerns the gene TP53 and triple-negative breast carcinoma.